FPGS and acute lymphoblastic leukemia: We have previously shown that loss of FPGS activity is a predominant mechanism underlying resistance to polyglutamatable antifolates, where 11 out of 14 antifolate-resistant human ALL sublines displayed drug resistance based on impaired FPGS activity [11].